Wei Kong
16Patents
4h-index
29Co-inventors
56Inventor score
Filing activity: Nov 10, 2009 → Oct 14, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8445254B2 | Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety | Human Necessities | 20 | Active |
| US9297015B2 | Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety | Human Necessities | 10 | Active |
| US9598697B2 | Recombinant bacterium to decrease tumor growth | Chemistry; Metallurgy | 7 | Active |
| US9885051B2 | Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety | Human Necessities | 6 | Active |
| US9481888B2 | Recombinant bacterium and methods of antigen and nucleic acid delivery | Chemistry; Metallurgy | 2 | Active |
| US10774334B2 | Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety | Human Necessities | 2 | Active |
| US11180765B2 | Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety | Human Necessities | 1 | Active |
| US9669005B2 | Use of naringenin in preparing drugs for preventing and/or treatment abdominal aortic aneurysm | Human Necessities | 0 | Active |
| US11564954B2 | Tumor-delivered multi-target therapeutics for colon cancer | Chemistry; Metallurgy | 0 | Active |
| US12414987B2 | Phosphorylated polypeptide antigen vaccine, preparation method therefor and application thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11519007B2 | Tumor-navigating, self-eradicating, trail-armed salmonella for precision cancer therapy | Emerging Cross-Sectional Technologies | 0 | Active |
| US11116831B2 | Chimeric norovirus P particle and preparation and use thereof | Human Necessities | 0 | Active |
| US10588955B2 | Streptococcus pneumoniae protein antigen, and preparation method and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10463741B2 | Non-gelatin vaccine protectant composition and live attenuated influenza vaccine | Chemistry; Metallurgy | 0 | Active |
| US11717542B2 | Using tumor-navigating Salmonella to modulate tumor metabolism | Emerging Cross-Sectional Technologies | 0 | Active |
| US11920139B2 | Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.